Hookipa PharmaHOOK
13F holders, Q2 2025 (June 30)26holders −5
1new positions
6sold out
1famous investor
$1.25avg. 13F price*
At the end of Q2 2025, 26 institutions reported holding Hookipa Pharma Inc. (HOOK) in their 13F filings, down 5 from Q1 2025. 1 opened new positions and 6 sold out. The largest holders were Gilead Sciences, Inc. ($2.4M), Baker Bros. Advisors LP ($1.0M) and Siren, L.L.C. ($711K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Hookipa Pharma Inc.
- CUSIP
- 43906K209
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 6 | $104K |
All 13F filers, Q1 2025 → Q2 2025: 31,150 shares bought and 149,337 shares sold, net −118,187 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Gilead Sciences, Inc. | 0.18% | No change | 1,875,945 | $2.4M |
| Baker Bros. Advisors LP | 0.01% | No change | 812,814 | $1.0M |
| Siren, L.L.C. | 0.04% | No change | 566,640 | $711K |
| FMR LLC | 0.00% | Reduce -4.5% | 334,030 | $419K |
| Vanguard Group Inc. | 0.00% | No change | 300,819 | $378K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.1% | 73,341 | $92K |
| Acadian Asset Management LLC | 0.00% | No change | 55,735 | $69K |
| Ikarian Capital, LLC | 0.02% | No change | 52,996 | $67K |
| Renaissance Technologies | 0.00% | Add +11.2% | 45,570 | $57K |
| Susquehanna International Group, LLP | 0.00% | Add +93.9% | 37,265 | $47K |
| Royal Bank of Canada | 0.00% | Add +27.1% | 28,852 | $36K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -15.8% | 23,948 | $30K |
| Morgan Stanley | 0.00% | Add +11.6% | 19,247 | $24K |
| State Street Corp. | 0.00% | No change | 16,967 | $21K |
| Northern Trust Corp. | 0.00% | No change | 15,661 | $20K |
| BlackRock, Inc. | 0.00% | No change | 12,250 | $15K |
| Boothbay Fund Management, LLC | 0.00% | No change | 11,688 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -32.4% | 3,481 | $4K |
| JPMorgan Chase & Co. | 0.00% | Reduce -12.0% | 815 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -9.1% | 500 | $625 |
| Bank of America Corp. | 0.00% | Add +1.5% | 481 | $604 |
| UBS Group AG | 0.00% | Reduce -99.8% | 63 | $79 |
| BNP Paribas Financial Markets | 0.00% | Add +24.2% | 41 | $51 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 33 | $41 |
| SBI Securities Co., Ltd. | 0.00% | No change | 13 | $16 |
| Simplex Trading, LLC | 0.00% | New | 341 | $0 |
"% of holder's portfolio" is HOOK's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.